Belpointe Asset Management LLC Has $881,000 Stake in iShares Biotechnology ETF $IBB

Posted by James Quigley on Oct 9th, 2025

Belpointe Asset Management LLC lowered its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.3% in the second quarter, Holdings Channel reports. The fund owned 6,964 shares of the financial services provider’s stock after selling 166 shares during the quarter. Belpointe Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $881,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Ramirez Asset Management Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter worth about $26,000. Berkshire Money Management Inc. bought a new position in shares of iShares Biotechnology ETF in the second quarter worth about $28,000. Financial Gravity Asset Management Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter worth about $30,000. Woodside Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the first quarter worth about $31,000. Finally, CX Institutional bought a new position in shares of iShares Biotechnology ETF in the first quarter worth about $32,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $151.99 on Thursday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $153.01. The firm has a 50-day moving average price of $140.21 and a 200-day moving average price of $130.36.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.